ImmunoCellular Therapeutics (IMUC) Tops Q1 EPS by 1c
Get Alerts IMUC Hot Sheet
Join SI Premium – FREE
ImmunoCellular Therapeutics (NYSE: IMUC) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Nayax completes $350M all-cash acquisition of IPS Group
- ESCO Technologies completes acquisition of Megger Group Limited
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share